EG vs PBYI · P/E 17, rev $8.03B vs P/E 4.3, rev $56.5M
Everest Group Ltd (EG) versus Puma Biotechnology Inc (PBYI) — a side-by-side from cached financials, not a winner call.
Everest Group Ltd (EG) is a insurance - reinsurance company listed on US.
Puma Biotechnology Inc (PBYI) is a biotechnology company listed on US.
Latest reported EG revenue for 2026-06-30 was $8.03B. Net income was $1.21B. Revenue was up 97.4% from 2026-03-31 to 2026-06-30. EG currently screens at market cap $14.52B and trailing P/E 17.2.
Latest reported PBYI revenue for 2026-06-30 was $56.5M. Net income was $8.2M. Revenue was up 26.1% from 2026-03-31 to 2026-06-30. PBYI currently screens at market cap $165.3M and trailing P/E 4.3.
EG currently screens at market cap $14.52B and trailing P/E 17.2. PBYI currently screens at market cap $165.3M and trailing P/E 4.3.
Not investment advice. Open the EG and PBYI stock pages for the full models.
Not investment advice.